Serum calcitonin response to induced hypercalcemia.

The rise in serum calcitonin (delta-CT240 min) has been measured during hypercalcemia induced by i.v. infusion of calcium gluconate. This calcium infusion test was used in a prospective screening for medullary carcinoma of the thyroid (MCT) in 4 families with Sipple's syndrome as well as in 3 sporadic cases of MCT. In 16 normal controls delta-CT240 was minus 0.2-+ 0.5 ng/ml (mean plus or minus 2 S.D.). Delta-CT240 was normal in 2 patients with chronic hypocalcemia. In all 14 MCT patients delta-CT240 was markedly higher (min-max 2.2-630 ng/ml), i.e. no false negatives were found. However, in these cases, the diagnosis was already evident from basal serum calcitonin (S-CT), which up to now has been our most sensitive diagnostic technique for MCT. 19 first-degree relatives of patients with Sipple's syndrome presented no signs of MCT. In 14 of these delta-CT240 was normal ("healthy relatives"), but in 5 it was slightly elevated, intermediate between the controls and the MCT patients. These 5 borderline cases were more sharply delineated from normal by delta-CT240 than by S-CT. Thus our calcium infusion test seems to be the most sensitive method for early diagnosis of occult MCT. We recommend the calcium infusion test for: (a) screening for MCT in all Sipple relatives with normal or only slightly elevated basal S-CT, (b) postoperative control in both sporadic and hereditary MCT, (c) investigation of supposed non-MCT tumours with calcitonin production.

[1]  O. Beahrs,et al.  Medullary carcinoma of the thyroid gland , 1975, Cancer.

[2]  P. Hedner,et al.  Screening for medullary carcinoma of the thyroid in families with Sipple's syndrome: evaluation of new stimulation tests , 1977, European journal of clinical investigation.

[3]  M. Åkerman,et al.  Diagnosis of medullary carcinoma of the thyroid by fine needle aspiration biopsy. , 2009, Acta medica Scandinavica.

[4]  M. Telenius‐Berg,et al.  Serum calcitonin in medullary thyroid carcinoma. Radioimmunoassay technique and diagnostic value. , 2009, Acta medica Scandinavica.

[5]  J. Doppman,et al.  Ectopic secretion of calcitonin by oat-cell carcinoma. , 1974, The New England journal of medicine.

[6]  D. Goltzman,et al.  Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma. , 1974, The New England journal of medicine.

[7]  G. Milhaud,et al.  Letter: Hypersecretion of calcitonin in neoplastic conditions. , 1974, Lancet.

[8]  K. Becker,et al.  Radioimmunoassay of calcitonin in human plasma. , 1974, Clinical chemistry.

[9]  L. Deftos.  Radioimmunoassay for calcitonin in medullary thyroid carcinoma. , 1974, JAMA.

[10]  A. Tashjian,et al.  C-cell hyperplasia preceding medullary thyroid carcinoma. , 1973, The New England journal of medicine.

[11]  F. Mitelman,et al.  Chromosomes in Sipple's syndrome. , 1973, Lancet.

[12]  H. Lemkes,et al.  Calcitonin secretion in medullary carcinoma of the thyroid. , 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[13]  A. Tashjian,et al.  Studies in familial (medullary) thyroid carcinoma. , 1972, Recent progress in hormone research.

[14]  J. Habener,et al.  Immunoassay for human calcitonin. II. Clinical studies. , 1971, Metabolism: clinical and experimental.

[15]  L. Deftos.  Immunoassay for human calcitonin. I. Method. , 1971, Metabolism: clinical and experimental.

[16]  A. Tashjian,et al.  Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay. , 1971, The New England journal of medicine.

[17]  A. Kassenaar,et al.  Radioimmunoassay of human plasma calcitonin. , 1971, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[18]  J. Hydovitz,et al.  Normal chromosomes in mucosol neuroma variant of medullary thyroid carcinoma syndrome. , 1970, Journal of medical genetics.

[19]  A. Tashjian,et al.  Immunoassay of human calcitonin. , 1970, The New England journal of medicine.

[20]  J. R. Fletcher.  Medullary (solid) carcinoma of the thyroid gland. A review of 249 cases. , 1970, Archives of surgery.

[21]  P. Byfield,et al.  A radioimmunoassay for human calcitonin M. , 1969, Lancet.

[22]  A. Steiner,et al.  STUDY OF A KINDRED WITH PHEOCHROMOCYTOMA, MEDULLARY THYROID CARCINOMA, HYPERPARATHYROIDISM AND GUSHING 'S DISEASE: MULTIPLE ENDOCRINE NEOPLASIA, TYPE 21 , 1968, Medicine.

[23]  O. Ljungberg,et al.  Medullary thyroid carcinoma and phaeochromocytoma: a familial chromaffinomatosis. , 1967, British medical journal.

[24]  R. Clark,et al.  Solid carcinoma of the thyroid gland. Analysis of 53 cases , 1967, Cancer.

[25]  C. Brown,et al.  Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid , 1966, Journal of clinical pathology.

[26]  W. Hartmann,et al.  Familial amyloid-producing medullary thyroid carcinoma and pheochromocytoma. A distinct genetic entity. , 1965, Annals of internal medicine.

[27]  J. Hazard,et al.  Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity. , 1959, The Journal of clinical endocrinology and metabolism.